ZS Pharma: Dr Robert Alexander Joins T3D Therapeutics' Scientific Advisory Board
Alzheimer's disease expert Dr Robert Alexander will help shape the future development path of T3D Therapeutics' lead drug candidate T3D-959 as a potential disease remedial therapy for Alzheimer's patients.
Read full article »
CEO
ZS Pharma develops and commercializes non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases.
Read more